Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Catalent

Three Stocks Turn $10,000 To $25,265 In Just 3 Months

Investors enjoyed a small S&P 500 rally in March. But there were much more lucrative places to put money in the month.

Investors Business Daily

Catalent Stock Showing Improved Relative Strength Rating

A Relative Strength Rating upgrade for Catalent shows improving technical performance. Will it continue?

Investors Business Daily

Two S&P 500 Stocks Turn $10,000 To $19,631 In Just 2 Months

February wasn't a great month for the S&P 500. But it still presented angles to nearly double your money with stocks in just two months.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Catalent Stock Sees Relative Strength Rating Jump To 83

A Relative Strength Rating upgrade for Catalent shows improving technical performance.

Investors Business Daily

Takeover News: February Opens With M&A Bang As Gold Miners, REITs Pitch $28 Billion In Deals

Mergers and acquisitions are off to a hot start in February as major gold miners and public storage REITs propose $28 billion in deals.

Investors Business Daily

Catalent Hits Four-Month High As Danaher Reportedly Mulls A Takeover

Catalent stock launched higher Monday on a rumor that Danaher could acquire it in a bid to compete with Thermo Fisher Scientific.

Investors Business Daily

Analysts Pound The Table For 11 Stocks Trading For 50% Off

Savvy investors know to stick with stocks in an uptrend. But analysts are still pounding the table for some S&P 500 stocks.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Benzinga's Top Ratings Upgrades, Downgrades For November 7, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022

Upgrades

Benzinga

S&P 500 Stock Market Winners Today

Oil stocks were S&P 500 winners Monday, including Diamondback Energy. Bristol Myers Squibb was among the big losers.

Investors Business Daily

Catalent Stock Is Generating Improved Relative Strength

A Relative Strength Rating upgrade for Catalent shows improving technical performance. Will it continue?

Investors Business Daily

Morgan Stanley Maintains Overweight Rating for Catalent: Here's What You Need To Know

Morgan Stanley has decided to maintain its Overweight rating of Catalent (NYSE:CTLT) and lower its price target from $145.00 to $132.00. Shares of Catalent are trading up 1.11% over the last 24 hours, at $101.06 per share. A move to $132.00 would account for a 30.62% increase from the current…

Benzinga

Catalent Shares Jump As Investors Cheer Revised, Better Than Expected FY22 Outlook

Catalent Inc (NYSE:CTLT) reported Q3 FY22 sales of $1.27 billion, +21% Y/Y as reported, or 23% in constant currency, edging out analysts' average expectation of $1.22 billion. Adjusted EPS of $1.04, compared to $0.82 last year, surpassed the consensus of $0.94. Adjusted EBITDA was $339 million, or a margin of 27%, compared…

Benzinga

Recap: Catalent Q3 Earnings

Catalent (NYSE:CTLT) reported its Q3 earnings results on Tuesday, May 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

How To Attend Catalent Q3 2022 Earnings Conference Call

Catalent (NYSE:CTLT) will host a conference call at 08:15 AM ET on May 3, 2022, to discuss Q3 2022 earnings results. How to Attend Catalent (CTLT) Conference Call Follow this link to access the live webcast.

Daily Mirror

UK vaccine centre that got £205m from government is sold off to US pharma giant

Campaigners branded the sale of the Vaccine Manufacturing and Innovation Centre (VMIC) 'beyond absurd' as the UK faces the risk of a new Covid variant in the future

The Independent UK

Sale of UK vaccine manufacturing plant branded ‘ridiculously short-sighted’

US firm Catalent confirmed on Wednesday it had acquired the site in Oxfordshire.

Benzinga

Catalent's Q2 Earnings Beat Street View, Lifts FY22 Guidance

Catalent Inc (NYSE: CTLT) has reported Q2 FY22 sales of $1.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Earnings Outlook For Catalent

Catalent (NYSE:CTLT) is set to give its latest quarterly earnings report on Tuesday, 2022-02-01. Here's what investors need to know before the announcement. Analysts estimate that Catalent will likely report an Earnings Per Share (EPS) of $0.83.

Benzinga

A Bearish Sign Appears On Catalent's Chart

If history is any guide, there may be trouble ahead for shares of Catalent (NYSE:CTLT). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

Expert Ratings For Catalent

Analysts have provided the following ratings for Catalent (NYSE:CTLT) within the last quarter:

Investors Business Daily

This Tattooed, Cowboy-Boot-Wearing Top CEO Refuses To Go Clean Cut

John Chiminski knows he doesn't fit the traditional image of a corporate bigwig. And the Catalent CEO is not about to change.

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

SP Global Market Intelligence

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.